DAVID M NIERMAN, MD
Osteopathic Medicine in New York, NY
License number
New York 148363
Category
Osteopathic Medicine
Type
Critical Care Medicine
License number
New York 148363
Category
Osteopathic Medicine
Type
Pulmonary Disease
Address
Address
5 Floor Bo Mt, New York, NY 10029
Phone
(212) 241-5656
(212) 241-8866 (Fax)
(212) 987-3100
(212) 731-5210 (Fax)
(212) 241-8866 (Fax)
(212) 987-3100
(212) 731-5210 (Fax)
Personal information
See more information about DAVID M NIERMAN at radaris.comName
Address
Phone
35 E 85Th St APT 14AN, New York, NY 10028
444 Neptune Ave APT 6P, Brooklyn, NY 11224
1 Gustave L Levy Pl, New York, NY 10029
301 53Rd St, New York, NY 10019
35 85Th St, New York, NY 10028
Professional information
At&Amp;T
Position:
Unified Communication- Solutions Executive at AT&T
Location:
Greater New York City Area
Industry:
Online Media
Work:
AT&T
since Nov 2009
-
Unified Communication- Solutions Executive
Switch and Data
Mar 2009 - Nov 2009
-
Eastern Regional Manager- Content & Entertainment
AT&T
Oct 2000 - Mar 2009
-
Application Networking Manager
Qwest Communications
Jan 1998 - Jan 2000
-
Senior Account Executive
Education:
State University of New York College at Buffalo 1986 - 1991
BS, Business Adminstation with concentration in accounting
BS, Business Adminstation with concentration in accounting
Skills:
Managed Services, Data Center, Enterprise Software, Integration, Unified Communications, Wireless
David M. Nierman, New York NY
Specialties:
Internist, Pulmonologist
Address:
One Gustave L. Levy Place, New York, NY 10029
Education:
Medical School - Sackler Fac. of Med., Tel Aviv Uni, MD
Tulane School of Public Health and Tropical Medicine
Long Island Jewish Medical Center (Residency - Internal Medicine)
St. Luke's-Roosevelt Hospital Ctr. (Fellowship - Pulmonary)
Tulane School of Public Health and Tropical Medicine
Long Island Jewish Medical Center (Residency - Internal Medicine)
St. Luke's-Roosevelt Hospital Ctr. (Fellowship - Pulmonary)
Languages:
English
Awards and Publications:
Weissman D, Morrison R, Meier D. Center to Advance Palliative Care Palliative Care Clinical Care and customer satisfaction metrics consensus recommendations. Journal of Palliative Medicine 2010; 13(2): 179-184.
Board certifications:
American Board of Internal Medicine, Critical Care Medicine (Internal Medicine), Pulmonary Disease (Internal Medicine)
About:
David M. Nierman is the Vice President of Medical Affairs and Chief Medical Officer of Mount Sinai Queens. He heads the medical staff, overseeing the consistent
delivery of high-q...
Chief Medical Officer And Vice President, Medical Affairs; Mount Sinai Queens At Mount Sinai Medical Center
Location:
Greater New York City Area
Industry:
Hospital & Health Care
Dr. David M Nierman, Long Island City NY - MD (Doctor of Medicine)
Specialties:
Critical Care Medicine, Pulmonology
Address:
Long Island City Office
2510 30Th Ave, Long Island City 11102
(718) 932-1000 (Phone), (718) 876-5969 (Fax)
Mount Sinai Hospital EMR
1 Gustave L Levy Pl SUITE 12, New York 10029
(212) 241-6794 (Phone)
2510 30Th Ave, Long Island City 11102
(718) 932-1000 (Phone), (718) 876-5969 (Fax)
Mount Sinai Hospital EMR
1 Gustave L Levy Pl SUITE 12, New York 10029
(212) 241-6794 (Phone)
Certifications:
Critical Care Medicine, 2012, Internal Medicine, 1984, Pulmonary Disease, 1988
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Tel Aviv University / Sackler Faculty of Medicine
Zucker Hillside Hospital
St Lukes/Roosevelt Hosp Ctr
Tel Aviv University / Sackler Faculty of Medicine
Zucker Hillside Hospital
St Lukes/Roosevelt Hosp Ctr
Method Of Determining Patient Neutrophil Activity And Apparatus For Practicing The Same
US Patent:
5529907, Jun 25, 1996
Filed:
Jan 19, 1994
Appl. No.:
8/182826
Inventors:
David M. Nierman - New York NY
Thomas H. Kalb - Scarsdale NY
Thomas H. Kalb - Scarsdale NY
International Classification:
C12Q 102, C12Q 100, C12M 134, G01N 3349
US Classification:
435 29
Abstract:
The present invention relates to a method of determining the metabolic state of neutrophils present in the body of a patient. In particular, the present invention involves the measurement of the rates of in vitro glycolysis in blood samples taken from individuals as a function of the number of selected cells present in the blood sample, including neutrophils and red blood cells. The physiologic information provided by the present method, which, for example, indicates whether an individual's neutrophils are in a quiescent, primed or activated state, allows the medical practitioner to attain a better understanding of the patient's condition and, consequently, assists in the diagnosis and formulation of proper treatment.
Biopsy Forceps
US Patent:
4880015, Nov 14, 1989
Filed:
Jun 3, 1988
Appl. No.:
7/202169
Inventors:
David M. Nierman - New York NY
International Classification:
A61B 1000
US Classification:
128751
Abstract:
This invention relates to a biopsy forcep for use in a flexible fiberoptic bronchoscope. More particularly, this invention is directed to a biopsy forcep having an increased range of operability when used in conjunction with the flexible fiberoptic bronchoscope when obtaining tissue samples such as smooth growths in the trachea or main stem bronchii.